XPO1 and colorectal cancer: We have also found that repressing the nuclear export of BATF2 by mutating its nuclear export sequence and suppressing the expression of chromosome region maintenance 1 (CRM1) might serve as potential therapeutic approaches for patients with colorectal cancer (9).